Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes

scientific article

Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023522266
P356DOI10.1186/1475-2840-11-86
P932PMC publication ID3461422
P698PubMed publication ID22828168
P5875ResearchGate publication ID230564520

P2093author name stringFrancisco J Tinahones
Badimon Lina
Bernal-Lopez M Rosa
Calleja Fernando
Gomez-Carrillo Victor
Gomez-Huelgas Ricardo
Llorente-Cortes Vicenta
Lopez-Carmona Dolores
P2860cites workIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) GroupQ29547282
TLR4 links innate immunity and fatty acid-induced insulin resistanceQ29617577
Progress and challenges in translating the biology of atherosclerosisQ29619982
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetesQ30891442
Oxidative stress is associated with impaired arterial elasticityQ33760960
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectivesQ34159834
Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention StudyQ35389741
Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistanceQ35540671
Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposureQ35752422
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.Q36755963
Possible involvement of Cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cellsQ36783935
Matrix metalloproteinases: useful and deleteriousQ36883870
Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPsQ37155389
AMPK and vasculoprotectionQ37812782
Necrotic cell death in atherosclerosis.Q37879605
Diabetic cardiovascular disease--AMP-activated protein kinase (AMPK) as a therapeutic targetQ38013204
LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.Q38311535
Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53.Q39937824
Hypercoagulability in venous and arterial thrombosisQ41431413
Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetesQ42153827
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion developmentQ42453290
Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosisQ42478535
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9.Q42790003
Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cellsQ43614849
Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanismQ44243303
Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factorsQ45156504
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE StudyQ45232445
Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertensionQ46748422
Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronariesQ47940260
Intensive glycemic control in the ACCORD and ADVANCE trialsQ53654194
[Release of nitric oxide induced by blood flow. Update and perspectives of research]Q74135559
Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient miceQ80092264
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertensionQ80506431
P407language of work or nameEnglishQ1860
P921main subjectmetabolic pathwayQ68685
biomarkerQ864574
type 2 diabetesQ3025883
P304page(s)86
P577publication date2012-07-24
P1433published inCardiovascular DiabetologyQ2468083
P1476titleAlterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes
P478volume11

Reverse relations

cites work (P2860)
Q34503055Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study
Q58614010MicroRNA profiling of diabetic atherosclerosis in a rat model
Q55089831MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway.
Q38688810P2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vessels

Search more.